LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 29

Search options

  1. Book ; Online ; E-Book: Immune rebalancing

    Boraschi, Diana / Penton-Rol, Giselle

    the future of immunosuppression

    2016  

    Author's details Diana Boraschi, Giselle Penton-Rol
    Keywords Immunopharmacology ; Immunosuppression
    Subject code 615.37
    Language English
    Size 1 Online-Ressource (xiii, 285 Seiten), Illustrationen
    Publisher Elsevier AP
    Publishing place Amsterdam
    Publishing country Netherlands
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT018907535
    ISBN 978-0-12-803336-4 ; 9780128033029 ; 0-12-803336-3 ; 0128033029
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article ; Online: Editorial: Women in cytokines and soluble mediators in immunity.

    Boraschi, Diana / Penton-Rol, Giselle / Amodu, Olukemi / Blomberg, Marita Troye

    Frontiers in immunology

    2024  Volume 15, Page(s) 1395165

    MeSH term(s) Female ; Humans ; Cytokines ; Immunity, Innate ; Inflammation Mediators
    Chemical Substances Cytokines ; Inflammation Mediators
    Language English
    Publishing date 2024-03-14
    Publishing country Switzerland
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2024.1395165
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System.

    Pentón-Rol, Giselle / Marín-Prida, Javier / McCarty, Mark F

    Current neuropharmacology

    2021  Volume 19, Issue 12, Page(s) 2250–2275

    Abstract: The edible cyanobacterium Spirulina platensis and its chief biliprotein C-Phycocyanin have shown protective activity in animal models of diverse human health diseases, often reflecting antioxidant and anti-inflammatory effects. The beneficial effects of ... ...

    Abstract The edible cyanobacterium Spirulina platensis and its chief biliprotein C-Phycocyanin have shown protective activity in animal models of diverse human health diseases, often reflecting antioxidant and anti-inflammatory effects. The beneficial effects of C-Phycocyanin seem likely to be primarily attributable to its covalently attached chromophore Phycocyanobilin (PCB). Within cells, biliverdin is generated from free heme and it is subsequently reduced to bilirubin. Although bilirubin can function as an oxidant scavenger, its potent antioxidant activity reflects its ability to inactivate some isoforms of NADPH oxidase. Free bilirubin can also function as an agonist for the aryl hydrocarbon receptor (AhR); this may explain its ability to promote protective Treg activity in cellular and rodent models of inflammatory disease. AhR agonists also promote transcription of the gene coding for Nrf-2, and hence can up-regulate phase 2 induction of antioxidant enzymes, such as HO-1. Hence, it is proposed that C-Phycocyanin/PCB chiefly exert their protective effects via inhibition of NADPH oxidase activity, as well as by AhR agonism that both induces Treg activity and up-regulates phase 2 induction. This simple model may explain their potent antioxidant/antiinflammatory effects. Additionally, PCB might mimic biliverdin in activating anti-inflammatory signaling mediated by biliverdin reductase. This essay reviews recent research in which CPhycocyanin and/or PCB, administered orally, parenterally, or intranasally, have achieved marked protective effects in rodent and cell culture models of Ischemic Stroke and Multiple Sclerosis, and suggests that these agents may likewise be protective for Alzheimer's disease, Parkinson's disease, and in COVID-19 and its neurological complications.
    MeSH term(s) Animals ; COVID-19 ; Dietary Supplements ; Humans ; Neurodegenerative Diseases/drug therapy ; Phycobilins ; Phycocyanin/pharmacology ; SARS-CoV-2
    Chemical Substances Phycobilins ; Phycocyanin (11016-15-2) ; phycocyanobilin (36NUT04V2K)
    Language English
    Publishing date 2021-04-08
    Publishing country United Arab Emirates
    Document type Journal Article
    ZDB-ID 2192352-8
    ISSN 1875-6190 ; 1570-159X
    ISSN (online) 1875-6190
    ISSN 1570-159X
    DOI 10.2174/1570159X19666210408123807
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Immune rebalancing

    Boraschi, D / Penton-Rol, Giselle

    the future of immunosuppression

    2016  

    Author's details [edited by] Diana Boraschi, Giselle Penton-Rol
    MeSH term(s) Immunosuppression ; Immune Tolerance
    Language English
    Size xiii, 284 pages :, illustrations
    Document type Book
    ISBN 9780128033029 ; 0128033029
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  5. Article: Nutraceutical and therapeutic potential of Phycocyanobilin for treating Alzheimer’s disease

    Piniella-Matamoros, Beatriz / Marín-Prida, Javier / Pentón-Rol, Giselle

    Journal of biosciences. 2021 June, v. 46, no. 2

    2021  

    Abstract: Alzheimer’s disease (AD) is a devastating neurodegenerative condition provoking the loss of cognitive and memory performances. Despite huge efforts to develop effective AD therapies, there is still no cure for this neurological condition. Here, we review ...

    Abstract Alzheimer’s disease (AD) is a devastating neurodegenerative condition provoking the loss of cognitive and memory performances. Despite huge efforts to develop effective AD therapies, there is still no cure for this neurological condition. Here, we review the main biological properties of Phycocyanobilin (PCB), accounting for its potential uses against AD. PCB, given individually or released in vivo from C-Phycocyanin (C-PC), acts as a bioactive-molecule-mediating antioxidant, is anti-inflammatory and has immunomodulatory activities. PCB/C-PC are able to scavenge reactive oxygen and nitrogen species, to counteract lipid peroxidation and to inhibit enzymes such as NADPH oxidase and COX-2. In animal models of multiple sclerosis and ischemic stroke, these compounds induce remyelination as demonstrated by electron microscopy and the expression of genes such as Mal up-regulation of and Lingo-1 down-regulation. These treatments also reduce pro-inflammatory cytokines levels and induce immune suppressive genes. PCB/C-PC protects isolated rat brain mitochondria and inactivate microglia, astrocytes and neuronal apoptosis mediators. Such processes are all involved in the pathogenic cascade of AD, and thus PCB may effectively mitigate the injury in this condition. Furthermore, PCB can be administered safely by oral or parenteral routes and therefore, could be commercially offered as a nutraceutical supplement or as a pharmaceutical drug.
    Keywords NAD(P)H oxidase (H2O2-forming) ; antioxidants ; apoptosis ; astrocytes ; brain ; cognition ; cytokines ; dietary supplements ; electron microscopy ; lipid peroxidation ; memory ; mitochondria ; neurons ; nitrogen ; oxygen ; rats ; sclerosis ; stroke ; therapeutics
    Language English
    Dates of publication 2021-06
    Size p. 42.
    Publishing place Springer India
    Document type Article
    Note NAL-AP-2-clean ; Review
    ZDB-ID 756157-x
    ISSN 0973-7138 ; 0250-5991
    ISSN (online) 0973-7138
    ISSN 0250-5991
    DOI 10.1007/s12038-021-00161-7
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article: Report on the Symposium "Molecular Mechanisms Involved in Neurodegeneration".

    Pentón-Rol, Giselle / Cervantes-Llanos, Majel

    Behavioral sciences (Basel, Switzerland)

    2018  Volume 8, Issue 1

    Abstract: The prevalence of neurodegenerative diseases is currently a major concern in public health because of the lack of neuroprotective and neuroregenerative drugs. The symposium on Molecular Mechanisms Involved in Neurodegeneration held in Varadero, Cuba, ... ...

    Abstract The prevalence of neurodegenerative diseases is currently a major concern in public health because of the lack of neuroprotective and neuroregenerative drugs. The symposium on Molecular Mechanisms Involved in Neurodegeneration held in Varadero, Cuba, updated the participants on the basic mechanisms of neurodegeneration, on the different approaches for drug discovery, and on early research results on therapeutic approaches for the treatment of neurodegenerative diseases. Alzheimer's disease and in silico research were covered by many of the presentations in the symposium, under the umbrella of the "State of the Art of Non-clinical Models for Neurodegenerative Diseases" International Congress, held from 20 to 24 June 2017. This paper summarizes the highlights of the symposium.
    Language English
    Publishing date 2018-01-18
    Publishing country Switzerland
    Document type Congress
    ISSN 2076-328X
    ISSN 2076-328X
    DOI 10.3390/bs8010016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Perspectives in immunopharmacology: the future of immunosuppression.

    Boraschi, Diana / Penton-Rol, Giselle

    Immunology letters

    2014  Volume 161, Issue 2, Page(s) 211–215

    Abstract: Modulation of immune responses for therapeutic purposes is a particularly relevant area, given the central role of anomalous immunity in a wide variety of diseases, from the most typically immune-related syndromes (autoimmune diseases, allergy and asthma, ...

    Abstract Modulation of immune responses for therapeutic purposes is a particularly relevant area, given the central role of anomalous immunity in a wide variety of diseases, from the most typically immune-related syndromes (autoimmune diseases, allergy and asthma, immunodeficiencies) to those in which altered immunity and inflammation define the pathological outcomes (chronic infections, tumors, chronic inflammatory and degenerative diseases, metabolic disorders, etc.). This brief review will summarize some of the most promising perspectives of immunopharmacology, in particular in the area of immunosuppression, by considering the following aspects:
    MeSH term(s) Biological Products/pharmacology ; Biological Products/therapeutic use ; Humans ; Immune System Diseases/drug therapy ; Immune System Diseases/genetics ; Immune System Diseases/immunology ; Immune System Diseases/metabolism ; Immunity/drug effects ; Immunity/physiology ; Immunomodulation/drug effects ; Immunomodulation/genetics ; Immunosuppression ; Microbiota/immunology ; Nanomedicine ; Precision Medicine
    Chemical Substances Biological Products
    Language English
    Publishing date 2014-10
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 445150-8
    ISSN 1879-0542 ; 0165-2478
    ISSN (online) 1879-0542
    ISSN 0165-2478
    DOI 10.1016/j.imlet.2013.11.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective.

    Pentón-Rol, Giselle / Marín-Prida, Javier / Falcón-Cama, Viviana

    Behavioral sciences (Basel, Switzerland)

    2018  Volume 8, Issue 1

    Abstract: Myelin loss has a crucial impact on behavior disabilities associated to Multiple Sclerosis (MS) and Ischemic Stroke (IS). Although several MS therapies are approved, none of them promote remyelination in patients, limiting their ability for chronic ... ...

    Abstract Myelin loss has a crucial impact on behavior disabilities associated to Multiple Sclerosis (MS) and Ischemic Stroke (IS). Although several MS therapies are approved, none of them promote remyelination in patients, limiting their ability for chronic recovery. With no available therapeutic options, enhanced demyelination in stroke survivors is correlated with a poorer behavioral recovery. Here, we show the experimental findings of our group and others supporting the remyelinating effects of C-Phycocyanin (C-PC), the main biliprotein of
    Language English
    Publishing date 2018-01-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ISSN 2076-328X
    ISSN 2076-328X
    DOI 10.3390/bs8010015
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Positive effects of Phycocyanobilin on gene expression in glutamate-induced excitotoxicity in SH-SY5Y cells and animal models of multiple sclerosis and cerebral ischemia.

    Gardón, Daniel Palenzuela / Cervantes-Llanos, Majel / Matamoros, Beatriz Piniella / Rodríguez, Hanlet Camacho / Tan, Chan-Yuan / Marín-Prida, Javier / Falcón-Cama, Viviana / Pavón-Fuentes, Nancy / Lemus, Jessica Gómez / Ruiz, Laura de la Caridad Bakos / Argudin, Tamara Díaz / Donato, Gillian Martínez / Perera, Yasser / Yang, Ke / Pentón-Rol, Giselle

    Heliyon

    2022  Volume 8, Issue 6, Page(s) e09769

    Abstract: Background: Oxidative stress has a predominant role in the pathogenesis of neurodegenerative diseases and therefore the modulation of genes and the identification of biological pathways associated with antioxidant therapies, have an impact on its ... ...

    Abstract Background: Oxidative stress has a predominant role in the pathogenesis of neurodegenerative diseases and therefore the modulation of genes and the identification of biological pathways associated with antioxidant therapies, have an impact on its treatment.
    Objective: The objective of this study was the comparison of 2 methods for the analysis of real-time PCR (qPCR) data, through the use of the evaluation of genes that mediate the effect of Phycocyanobilin (PCB) and its validation in animal models.
    Methods: We evaluated the effect of PCB:" in vitro" on gene modulation through qPCR analyzed by parametric ANOVA and multivariate principal component analysis (PCA) in a model of glutamate-induced excitotoxicity in the SH-SY5Y cell line and" in vivo"; in animal models of multiple sclerosis (MS) and cerebral ischemia (CI).
    Results: The results showed that PCA is a robust and powerful method that allows the assessment of gene expression profiles. We detected the significant down-regulation of the
    Conclusion: We concluded that the mechanisms by which PCB protected cells included the reduction of oxidative stress damage, which could contribute to its clinical efficacy for the treatment of neurodegenerative diseases.
    Language English
    Publishing date 2022-06-20
    Publishing country England
    Document type Journal Article
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2022.e09769
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Novel Insights into the Molecular Mechanisms Involved in the Neuroprotective Effects of C-Phycocyanin against Brain Ischemia in Rats.

    Marín-Prida, Javier / Liberato, José Luiz / Llópiz-Arzuaga, Alexey / Stringhetta-Padovani, Karina / Pavón-Fuentes, Nancy / Leopoldino, Andréia Machado / Cruz, Osmany Guirola / González, Ignacio Hernández / Pérez, Mariela León / Camins, Antoni / Ferreira Dos Santos, Wagner / Uyemura, Sergio Akira / Pardo-Andreu, Gilberto L / Pentón-Rol, Giselle

    Current pharmaceutical design

    2022  Volume 28, Issue 14, Page(s) 1187–1197

    Abstract: Background: Ischemic stroke produces a large health impact worldwide, with scarce therapeutic options.: Objective: This study aimed to reveal the role of NADPH oxidase and neuroinflammatory genes in the cerebral anti-ischemic effects of C-Phycocyanin ...

    Abstract Background: Ischemic stroke produces a large health impact worldwide, with scarce therapeutic options.
    Objective: This study aimed to reveal the role of NADPH oxidase and neuroinflammatory genes in the cerebral anti-ischemic effects of C-Phycocyanin (C-PC), the chief biliprotein of Spirulina platensis.
    Methods: Rats with either focal cerebral ischemia/reperfusion (I/R) or acute brain hypoperfusion, received C-PC at different doses, or a vehicle, for up to 6 h post-stroke. Neurological, behavioral and histochemical parameters were assessed in I/R rats at 24 h. Cerebral gene expression and hippocampal neuron viability were evaluated in hypoperfused rats at acute (24 h) or chronic phases (30 days), respectively. A molecular docking analysis of NOX2 and C-PC-derived Phycocyanobilin (PCB) was also performed.
    Results: C-PC, obtained with a purity of 4.342, significantly reduced the infarct volume and neurological deficit in a dose-dependent manner, and improved the exploratory activity of I/R rats. This biliprotein inhibited NOX2 expression, a crucial NADPH oxidase isoform in the brain, and the superoxide increase produced by the ischemic event. Moreover, C-PC-derived PCB showed a high binding affinity in silico with NOX2. C-PC downregulated the expression of pro-inflammatory genes (IFN-γ, IL-6, IL-17A, CD74, CCL12) and upregulated immune suppressive genes (Foxp3, IL-4, TGF-β) in hypoperfused brain areas. This compound also decreased chronic neuronal death in the hippocampus of hypoperfused rats.
    Conclusion: These results suggest that the inhibition of cerebral NADPH oxidase and the improvement of neuroinflammation are key mechanisms mediating the neuroprotective actions of C-PC against brain ischemia.
    MeSH term(s) Animals ; Brain Ischemia/drug therapy ; Brain Ischemia/metabolism ; Disease Models, Animal ; Molecular Docking Simulation ; NADPH Oxidases/metabolism ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use ; Phycocyanin/pharmacology ; Phycocyanin/therapeutic use ; Rats ; Reperfusion Injury/drug therapy
    Chemical Substances Neuroprotective Agents ; Phycocyanin (11016-15-2) ; NADPH Oxidases (EC 1.6.3.-)
    Language English
    Publishing date 2022-05-15
    Publishing country United Arab Emirates
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1304236-1
    ISSN 1873-4286 ; 1381-6128
    ISSN (online) 1873-4286
    ISSN 1381-6128
    DOI 10.2174/1381612828666220506145542
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top